Shoulder Innovations Inc(SI) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 30 at 7:41 PM ET (Korea 10/31 08:41)
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -1.7 | Insider Own | 45.32% | Shs Outstand | 20.8M | Perf Week | -2.7% |
| Market Cap | 0.40B | Forward P/E | - | EPS next Y | 15.19% | Insider Trans | -2.55% | Shs Float | 11.4M | Perf Month | 2.03% |
| Enterprise Value | 0.31B | PEG | - | EPS next Q | -0.49 | Inst Own | 40.07% | Short Float | 6.24% | Perf Quarter | -14.52% |
| Income | -0.04B | P/S | 6.63 | EPS this Y | 60.2% | Inst Trans | 3.5% | Short Ratio | 6.15 | Perf Half Y | 41.6% |
| Sales | 0.06B | P/B | 3.2 | EPS next 5Y | 32.53% | ROA | -30.49% | Short Interest | 0.71M | Perf YTD | 33.78% |
| Book/sh | 5.97 | P/C | 4.02 | EPS past 3/5Y | -75.53% - | ROE | -40.54% | 52W High | -22.22% ($24.59) | Perf Year | 60.76% |
| Cash/sh | 4.75 | P/FCF | - | Sales past 3/5Y | 56.68% - | ROIC | -25.18% | 52W Low | 75.18% ($10.92) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -7.99% | Gross Margin | 70.53% | Volatility(W/M) | 6.3% 5.24% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 5.23 | Sales Y/Y TTM | 60.9% | Oper. Margin | -58.53% | ATR (14) | 1.06 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 8.92 | EPS Q/Q | 48.07% | Profit Margin | -58.33% | RSI (14) | 50.83 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 10.71 | Sales Q/Q | 55.95% | SMA20 | 1.33% ($18.88) | Beta | -1.59 | Target Price | $26.5 |
| Payout | - | Debt/Eq | 0.12 | Earnings | 2026/11/5 | SMA50 | -0.28% ($19.18) | Rel Volume | 1.03 | Prev Close | $20.44 |
| Employees | 75 | LT Debt/Eq | 0.12 | EPS/Sales Surpr. | -6.87% 3.71% | SMA200 | 12.48% ($17.01) | Avg Volume(3M) | 0.12M | Price | $19.13 |
| IPO | 2025/7/31 | Option/Short | No/Yes | Trades | 1496 | Volume | 119,342 | Change | -6.41% |
A US orthopedic medical device company specializing in shoulder arthroplasty. It focuses on reducing glenoid loosening—a leading cause of shoulder replacement failure—through its patented InSet glenoid design, and is rapidly expanding its surgeon user base in the shoulder replacement market.
Over the past 1 year, roughly in the middle
22% below its 1-year high.
Traded about as much as usual. That is 103% of its average volume.
Next earnings report: November 5
4 days to go.
SI has a sound balance sheet but weak earning power
Of every $100 in sales, $58.53 is lost.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +60.2% this year.
Tap to view numbers
Relative to sales, the price is about the industry average
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $663. Peers typically go for $326.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have paid off
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership looks stable
Institutions hold 40.1%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
LYTE Roundhill Photonics & Optics ETF <0.01% 
IWC iShares Micro-Cap ETF <0.01% 
CAS Simplify China A Shares PLUS Income ETF <0.01% 
AVSC Avantis U.S Small Cap Equity ETF <0.01% 
ITWO ProShares Russell 2000 High Income ETF <0.01% Special products that amplify (leveraged) or invert this single stock. They decay quickly and are not for long-term holding.
GLD SPDR Gold Shares 134.7B 
IAU iShares Gold Trust 59.8B 
GLDM SPDR Gold MiniShares Trust 30.4B 
SLV iShares Silver Trust 26.2B 
GDX VanEck Gold Miners ETF 25.1B It ranks #63 of 142 in the industry
Based on market cap of $398M.
NPCE#62 NeuroPace Inc $422M PER - SI#63 Shoulder Innovations Inc $398M PER - 
RCEL#64 AVITA Medical Inc $389M PER - 
OFIX#65 Orthofix Medical Inc $369M PER - 
VMD#66 Viemed Healthcare Inc $368M PER 26.4 
FAQ
What kind of company is SI?
SI belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of SI?
The market cap of SI is approximately $398M, ranking 3,329 within its sector.
What is the 52-week high and low for SI?
SI has recorded a 52-week high of $24.59 and a low of $10.92.
